{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:28:03Z","timestamp":1791217683409,"version":"4.1.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.lungcan.2013.07.004","type":"journal-article","created":{"date-parts":[[2013,8,9]],"date-time":"2013-08-09T22:49:43Z","timestamp":1376088583000},"page":"171-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Response to dasatinib in a patient with SQCC of the lung harboring a discoid-receptor-2 and synchronous chronic myelogenous leukemia"],"prefix":"10.1016","volume":"82","clinical-trial-number":[{"clinical-trial-number":"nct01491633","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01514864","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Vincenzo","family":"Pitini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Arrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Di Mirto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Mondello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Altavilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"May (5)","key":"10.1016\/j.lungcan.2013.07.004_bib0005","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/embo-reports\/kve094","article-title":"The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism","volume":"2","author":"Labrador","year":"2001","journal-title":"EMBO Rep"},{"issue":"June (1)","key":"10.1016\/j.lungcan.2013.07.004_bib0010","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1158\/2159-8274.CD-11-0005","article-title":"Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer","volume":"1","author":"Hammerman","year":"2011","journal-title":"Cancer Discov"},{"key":"10.1016\/j.lungcan.2013.07.004_bib0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2008.10.014","article-title":"Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib","volume":"599","author":"Day","year":"2008","journal-title":"Eur J Pharmacol"},{"issue":"September (7417)","key":"10.1016\/j.lungcan.2013.07.004_bib0020","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature11404","article-title":"Comprehensive genomic characterization of squamous cell lung cancers","volume":"489","author":"Cancer Genome Atlas Research Network","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2013.07.004_bib0025","article-title":"Multipllex testing for driver mutations in squamous cell carcinomas of the lung","volume":"30","author":"Paul Paik","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2013.07.004_bib0030","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1200\/JCO.2010.30.5474","article-title":"Phase II study of dasatinib in patients with advanced non\u2013small-cell lung cancer","volume":"28","author":"Johnson","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2013.07.004_bib0035","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1200\/JCO.2009.25.4029","article-title":"Phase I\/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancer","volume":"28","author":"Haura","year":"2010","journal-title":"J Clin Oncol"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500213003139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500213003139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T19:24:04Z","timestamp":1563650644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500213003139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0169500213003139"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2013.07.004","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Response to dasatinib in a patient with SQCC of the lung harboring a discoid-receptor-2 and synchronous chronic myelogenous leukemia","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2013.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}